Results 151 to 160 of about 12,929 (212)

A phase I, open-label, study of GSK2879552, a lysine-specific demethylase 1 (LSD1) inhibitor, in patients with relapsed/refractory small cell lung carcinoma (SCLC) [PDF]

open access: bronze, 2016
Víctor Moreno   +8 more
openalex   +1 more source

Correction: LSD1 is required for euchromatic origin firing and replication timing. [PDF]

open access: yesSignal Transduct Target Ther
Wang Y   +9 more
europepmc   +1 more source

Regulation of Lipogenic Gene Expression by Lysine-specific Histone Demethylase-1 (LSD1)

open access: green, 2014
Arian Abdulla   +7 more
openalex   +1 more source

GPX3 Overexpression Ameliorates Cardiac Injury Post Myocardial Infarction Through Activating LSD1/Hif1α Axis. [PDF]

open access: yesJ Cell Mol Med
Jiang QQ   +14 more
europepmc   +1 more source

RETRACTED: Long Noncoding RNA LINC00673 Is Activated by SP1 and Exerts Oncogenic Properties by Interacting with LSD1 and EZH2 in Gastric Cancer [PDF]

open access: hybrid, 2017
Mingde Huang   +7 more
openalex   +1 more source

LincRNAFEZF1-AS1 represses p21 expression to promote gastric cancer proliferation through LSD1-Mediated H3K4me2 demethylation [PDF]

open access: gold, 2017
Yan-wen Liu   +8 more
openalex   +1 more source

Discovery of novel dual-target inhibitors of LSD1/EGFR for non-small cell lung cancer therapy. [PDF]

open access: yesActa Pharmacol Sin
Wei Y   +6 more
europepmc   +1 more source

Coordinated neuron-specific splicing events restrict nucleosome engagement of the LSD1 histone demethylase complex. [PDF]

open access: yesCell Rep
Porter RS   +15 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy